Login
Navigate Fool.com
Will INSM beat
the market?

INSMED, INC.

NASDAQ: INSM

Community Rating: 4 Stars: Favorite

12.44 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.40
Previous Close $12.44
Daily Range $11.48 - $12.89
52-Week Range $2.69 - $13.44
Market Cap $395.5M
P/E Ratio -7.27
Dividend (Yield) $0.00 (0.0%)
Volume 668,607
Average Daily Volume 391,323
Current FY EPS -$1.62

How do you think INSM
will perform against the market?

Top INSM Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted November 11, 2011

Insmed stock has been volatile since the company first reported in August that the FDA had placed their phase III antibiotic on clinical hold due to a cancer signal in rat studies. The looming predica … More

0 Replies Reply Report this Post
 

obiwankenobe1250 (< 20)
Submitted March 3, 2007

Voraciously consuming an inordinate amount of cash relative to its revenues. Long term prospects had better pan out, because the near term looks pretty dismal. And besides, downwithpumpers provided … More

0 Replies Reply Report this Post

News & Commentary

Why Insmed Shares Soared

An analyst powwow sends Insmed higher, but are shares now overvalued?

2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed

Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU

Insmed Loss Deepens in Q4, Narrows in 2012

The clinical-stage pharmaceutical company reports no revenues and net losses for both Q4 and 2012.

5 Reasons to Worry About Next Week

These five companies are going the wrong way on the bottom line.

Insmed Earnings: An Early Look

Let's look forward to this company's next earnings report.

Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

The Best of 2012: Insmed

Now we begin our look at the top gaining 25 stocks in the healthcare space with #25, up 134% this year, Insmed.

3 Stocks Near 52-Week Highs Worth Selling

Are these stocks sells or belles? You be the judge!

See More INSM News...

Sector

Healthcare

Industry

Drugs

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks